Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Outcomes of Early Versus Delayed Management of Iraqi Patients With Rheumatoid Arthritis With Etanercept

NCT04267614 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT04267614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04267614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Outcomes of Early Versus Delayed Management of Iraqi Patients With Rheumatoid Arthritis With Etanercept
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
November 1, 2018
Completion date
December 1, 2018
Enrollment
1,226 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis rheumatoid